SCHEMBL23370712

SCHEMBL23370712

O=c1c(C(O)O)ccc(-c2ccccn2)n1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 1/20 0.39
ALDH1A1 P00352 1/20 0.38
KDM4E B2RXH2 5/20 0.37
LMNA P02545 3/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
NPC1 O15118 2/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
ATM Q13315 1/20 0.36
CYP1A2 P05177 2/20 0.36
POLB P06746 2/20 0.36
CCR1 P32246 1/20 0.36
CCR5 P51681 1/20 0.36
CCR8 P51685 1/20 0.36
METAP1 P53582 1/20 0.36
BLM P54132 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377597 0.78 KDM4E (0.42) FEN1ALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL19429624 0.78 KDM4E (0.43) FEN1ALDH1A1KDM4ELMNAGAA
SCHEMBL29626163 0.78 KDM4E (0.42) FEN1ALDH1A1KDM4ELMNAL3MBTL1
SCHEMBL19429657 0.78 NPC1 (0.41) FEN1ALDH1A1KDM4ELMNAGAA
SCHEMBL19429626 0.77 FEN1 (0.39) FEN1ALDH1A1KDM4ELMNAGAA
SCHEMBL30672122 0.76 GRM5 (0.40) FEN1ALDH1A1KDM4ENPC1SMN1; SMN2
SCHEMBL19377934 0.74 GRIA1 (0.50) FEN1ALDH1A1KDM4EHPGDMAPT
SCHEMBL29626177 0.74 GRIA1 (0.50) FEN1ALDH1A1KDM4EHPGDMAPT
SCHEMBL28681776 0.74 ALDH1A1 (0.43) ALDH1A1KDM4ELMNANPC1MAPT
SCHEMBL19403731 0.71 KDM4E (0.40) FEN1ALDH1A1KDM4ELMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210147430-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS INCYTE CORPORATION 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147430-A1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS MERTK, MAP3K15, MAP3K5 FEN1 1798/4885ALDH1A1 2279/4885KDM4E 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.